OncoTAb Publishes Results on New Blood Test That Aids in Early Breast Cancer Detection
Summary
The results showed that the OncoTAb test identified breast cancer growth up to two years before mammography diagnosis.An increase in their Personal Score will indicate that a woman should seek further medical consultation and investigation via imaging modalities that are not impacted by dense breast tissue.This discovery led to the OncoTAb Agkura™ Personal Score blood test.Studies related to this test were published recently in a scientific journal.The results showed that the OncoTAb test identified breast cancer growth up to two years before mammography diagnosis.For more information or to order the test, visit www.Oncotab.com or watch their video at: https://www.youtube.com/watch?v=zHaArzICjGYThis press release is neither an offer to sell nor the solicitation of an offer to buy shares or any other security in any jurisdiction.About OncoTAb, Inc.OncoTAb (www.OncoTAb.com) is a University of North Carolina at Charlotte (UNCC) spin-out company with a patent-protected technology that is being used to address unmet cancer diagnosis and treatment needs.